CelAgace™ OraRinse Solution for Treatment of Candidiasis

Clinical trial NCT03250923 · UNKNOWN

Trial details

NCT number: NCT03250923
Sponsor: CelaCare Technologies, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Candidiasis, Oral

Start date: 2024-09-01
Primary completion: 2024-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.